Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. | Chief Financial Officer | Common Stock | 496K | $2.78M | $5.60 | Mar 6, 2024 | Direct |
Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.2K | Mar 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc. | Mar 6, 2024 | 1 | -$195K | 4 | Mar 7, 2024 | Chief Financial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Feb 20, 2024 | 1 | $0 | 4 | Feb 22, 2024 | Chief Financial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2023 | 1 | -$100K | 4/A | Feb 22, 2024 | Chief Financial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2023 | 2 | -$101K | 4 | Mar 6, 2023 | Chief Financial Officer |
AVTX | Avalo Therapeutics, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Director |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2022 | 4 | -$36.8K | 4 | Mar 4, 2022 | Chief Financial Officer |
AVTX | Avalo Therapeutics, Inc. | Dec 31, 2021 | 1 | $0 | 4 | Jan 4, 2022 | Director |
AVTX | Avalo Therapeutics, Inc. | Sep 30, 2021 | 1 | $0 | 4 | Oct 4, 2021 | Director |
AVTX | Cerecor Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
AVTX | Cerecor Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
AUPH | Aurinia Pharmaceuticals Inc. | May 11, 2021 | 1 | $9.74K | 4 | May 11, 2021 | Chief Financial Officer |